Please enable JavaScript to continue using this application.

Compare $ANIK vs $UPB | Chartloom

Compare

$ANIK vs $UPB

Anika Therapeutics Inc · Upstream Bio Inc

ANIK

Anika Therapeutics Inc

UPB

Upstream Bio Inc

Compare $ANIK vs $UPB

Comparing Anika Therapeutics Inc and Upstream Bio Inc

ANIKAnika Therapeutics Inc

UPBUpstream Bio Inc

ANIKAnika Therapeutics Inc

Market cap

$262M

P/E (TTM)

—

Forward P/E (NTM)

57.30x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

-2.5%

YTD performance

109.4%

52W performance

111.9%

FCF yield

0.2%

UPBUpstream Bio Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

168.72x

Rev growth (TTM)

16.0%

YTD performance

-82.6%

52W performance

-75.2%

FCF yield

-53.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIK

UPB

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

UPB

Upstream Bio Inc

Market Cap

ANIK$262M

UPB$256M

Enterprise Value

ANIK$224M

UPB$176M

Price

ANIK$19.58

UPB$4.70

P/E Ratio

ANIKN/A

UPBN/A

P/S Ratio

ANIK2.17x

UPB80.99x

EV/Sales

ANIK1.85x

UPB55.85x

EV/EBITDA

ANIK84.97x

UPB0.00x

P/B Ratio

ANIK1.86x

UPB1.02x

P/FCF Ratio

ANIK466.16x

UPBN/A

EV/FCF

ANIK397.81x

UPB-1.29x

PEG Ratio

ANIKN/A

UPBN/A

Forward P/E (NTM)

ANIK57.30x

UPBN/A

Forward P/S (NTM)

ANIK2.09x

UPB168.72x

Revenue (TTM)

ANIK$121M

UPB$3M

Revenue Growth (YoY)

ANIK-2.5%

UPB16.0%

Forward Rev Growth

ANIK5.2%

UPB-48.7%

Gross Margin (TTM)

ANIK62.2%

UPB0.0%

Operating Margin (TTM)

ANIK0.0%

UPB0.0%

EBITDA Margin (TTM)

ANIK2.2%

UPB-5376.3%

Net Margin (TTM)

ANIK-3.1%

UPB-4955.7%

FCF Margin (TTM)

ANIK0.5%

UPB-4321.2%

Net Income (TTM)

ANIK$-4M

UPB$-157M

FCF (TTM)

ANIK$562K

UPB$-136M

EPS (TTM)

ANIK-$0.28

UPB-$2.87

ROE (TTM)

ANIK-270.0%

UPB-4840.0%

ROA (TTM)

ANIK-204.0%

UPB-4657.0%

ROIC (TTM)

ANIK-270.0%

UPB-4840.0%

Cash

ANIK$38M

UPB$79M

Debt

ANIK$0

UPB$0

Net Cash/Debt

ANIK$38M

UPB$79M

Current Ratio (TTM)

ANIK4.48x

UPB27.99x

Quick Ratio (TTM)

ANIK3.05x

UPB27.84x

Debt/Equity (TTM)

ANIK0.00x

UPB0.00x

Debt/Assets (TTM)

ANIK0.0%

UPB0.0%

Interest Coverage (TTM)

ANIKN/A

UPBN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

UPB0.00x

Beta

ANIK0.23

UPB2.30

52W Performance

ANIK111.9%

UPB-75.2%

YTD Performance

ANIK109.4%

UPB-82.6%

% from 52W High

ANIK-14.4%

UPB-86.0%

% from 52W Low

ANIK125.8%

UPB7.7%

Asset Turnover (TTM)

ANIK0.65x

UPB0.01x

FCF Yield (TTM)

ANIK0.2%

UPB-53.4%

Earnings Yield (TTM)

ANIK-1.4%

UPB-61.2%

Dividend Yield (TTM)

ANIKN/A

UPBN/A

Rule of 40

ANIK-2.0

UPB-4,305.2

EV/GP/RG

ANIK0.81

UPBN/A

Ticker research

View ANIK research View UPB research

Metric	ANIK Anika Therapeutics Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$262M	$256M
Enterprise Value	$224M	$176M
Price	$19.58	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	80.99x
EV/Sales	1.85x	55.85x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.02x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	168.72x
Revenue & Growth
Revenue (TTM)	$121M	$3M
Revenue Growth (YoY)	-2.5%	16.0%
Forward Rev Growth	5.2%	-48.7%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	-5376.3%
Net Margin (TTM)	-3.1%	-4955.7%
FCF Margin (TTM)	0.5%	-4321.2%
Net Income (TTM)	$-4M	$-157M
FCF (TTM)	$562K	$-136M
EPS (TTM)	-$0.28	-$2.87
ROE (TTM)	-270.0%	-4840.0%
ROA (TTM)	-204.0%	-4657.0%
ROIC (TTM)	-270.0%	-4840.0%
Financial Health
Cash	$38M	$79M
Debt	$0	$0
Net Cash/Debt	$38M	$79M
Current Ratio (TTM)	4.48x	27.99x
Quick Ratio (TTM)	3.05x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.30
52W Performance	111.9%	-75.2%
YTD Performance	109.4%	-82.6%
% from 52W High	-14.4%	-86.0%
% from 52W Low	125.8%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.01x
FCF Yield (TTM)	0.2%	-53.4%
Earnings Yield (TTM)	-1.4%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	-4,305.2
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View UPB research

Valuation

P/S Ratio

ANIK

2.17x

UPB

80.99x

EV/FCF

UPB

-1.29x

ANIK

397.81x

Growth & revenue

Revenue Growth TTM

UPB

16.0%

ANIK

-2.5%

Forward Revenue Growth

ANIK

5.2%

UPB

-48.7%

Profitability & performance

Gross Margin

ANIK

62.2%

UPB

0.0%

ROE

ANIK

-270.0%

UPB

-4840.0%

FCF Yield %

ANIK

0.2%

UPB

-53.4%

52-Week Performance

ANIK

111.9%

UPB

-75.2%

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

UPB

Upstream Bio Inc

Market Cap

ANIK$262M

UPB$256M

Enterprise Value

ANIK$224M

UPB$176M

Price

ANIK$19.58

UPB$4.70

P/E Ratio

ANIKN/A

UPBN/A

P/S Ratio

ANIK2.17x

UPB80.99x

EV/Sales

ANIK1.85x

UPB55.85x

EV/EBITDA

ANIK84.97x

UPB0.00x

P/B Ratio

ANIK1.86x

UPB1.02x

P/FCF Ratio

ANIK466.16x

UPBN/A

EV/FCF

ANIK397.81x

UPB-1.29x

PEG Ratio

ANIKN/A

UPBN/A

Forward P/E (NTM)

ANIK57.30x

UPBN/A

Forward P/S (NTM)

ANIK2.09x

UPB168.72x

Revenue (TTM)

ANIK$121M

UPB$3M

Revenue Growth (YoY)

ANIK-2.5%

UPB16.0%

Forward Rev Growth

ANIK5.2%

UPB-48.7%

Gross Margin (TTM)

ANIK62.2%

UPB0.0%

Operating Margin (TTM)

ANIK0.0%

UPB0.0%

EBITDA Margin (TTM)

ANIK2.2%

UPB-5376.3%

Net Margin (TTM)

ANIK-3.1%

UPB-4955.7%

FCF Margin (TTM)

ANIK0.5%

UPB-4321.2%

Net Income (TTM)

ANIK$-4M

UPB$-157M

FCF (TTM)

ANIK$562K

UPB$-136M

EPS (TTM)

ANIK-$0.28

UPB-$2.87

ROE (TTM)

ANIK-270.0%

UPB-4840.0%

ROA (TTM)

ANIK-204.0%

UPB-4657.0%

ROIC (TTM)

ANIK-270.0%

UPB-4840.0%

Cash

ANIK$38M

UPB$79M

Debt

ANIK$0

UPB$0

Net Cash/Debt

ANIK$38M

UPB$79M

Current Ratio (TTM)

ANIK4.48x

UPB27.99x

Quick Ratio (TTM)

ANIK3.05x

UPB27.84x

Debt/Equity (TTM)

ANIK0.00x

UPB0.00x

Debt/Assets (TTM)

ANIK0.0%

UPB0.0%

Interest Coverage (TTM)

ANIKN/A

UPBN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

UPB0.00x

Beta

ANIK0.23

UPB2.30

52W Performance

ANIK111.9%

UPB-75.2%

YTD Performance

ANIK109.4%

UPB-82.6%

% from 52W High

ANIK-14.4%

UPB-86.0%

% from 52W Low

ANIK125.8%

UPB7.7%

Asset Turnover (TTM)

ANIK0.65x

UPB0.01x

FCF Yield (TTM)

ANIK0.2%

UPB-53.4%

Earnings Yield (TTM)

ANIK-1.4%

UPB-61.2%

Dividend Yield (TTM)

ANIKN/A

UPBN/A

Rule of 40

ANIK-2.0

UPB-4,305.2

EV/GP/RG

ANIK0.81

UPBN/A

Ticker research

View ANIK research View UPB research

Metric	ANIK Anika Therapeutics Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$262M	$256M
Enterprise Value	$224M	$176M
Price	$19.58	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	80.99x
EV/Sales	1.85x	55.85x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.02x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	168.72x
Revenue & Growth
Revenue (TTM)	$121M	$3M
Revenue Growth (YoY)	-2.5%	16.0%
Forward Rev Growth	5.2%	-48.7%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	-5376.3%
Net Margin (TTM)	-3.1%	-4955.7%
FCF Margin (TTM)	0.5%	-4321.2%
Net Income (TTM)	$-4M	$-157M
FCF (TTM)	$562K	$-136M
EPS (TTM)	-$0.28	-$2.87
ROE (TTM)	-270.0%	-4840.0%
ROA (TTM)	-204.0%	-4657.0%
ROIC (TTM)	-270.0%	-4840.0%
Financial Health
Cash	$38M	$79M
Debt	$0	$0
Net Cash/Debt	$38M	$79M
Current Ratio (TTM)	4.48x	27.99x
Quick Ratio (TTM)	3.05x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.30
52W Performance	111.9%	-75.2%
YTD Performance	109.4%	-82.6%
% from 52W High	-14.4%	-86.0%
% from 52W Low	125.8%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.01x
FCF Yield (TTM)	0.2%	-53.4%
Earnings Yield (TTM)	-1.4%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	-4,305.2
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View UPB research